2011年

1. Tada T, Kimura T, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Nakashima H, Ito A, Siode N, Namura M, Inoue N, Nishikawa H, Nakao K, Mitsudo K; j-Cypher Registry Investigators. Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol. 2011 Apr 15;107(8):1155-62. Epub 2011 Feb 4.
2. Marui A, Kimura T, Tanaka S, Miwa S, Yamazaki K, Minakata K, Nakata T, Ikeda T, Furukawa Y, Kita T, Sakata R; CREDO-Kyoto Investigators. Coronary revascularization in patients with liver cirrhosis. Ann Thorac Surg. 2011 May;91(5):1393-9. Epub 2011 Mar 10.
3. Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, Ono K, Shioi T, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Kimura T. Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J. 2011;75(5):1130-7. Epub 2011 Mar 30.
4. Doi T, Makiyama T, Morimoto T, Haruna Y, Tsuji K, Ohno S, Akao M, Takahashi Y, Kimura T, Horie M. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome. Circ Cardiovasc Genet. 2011 Jun;4(3):253-60. Epub 2011 Apr 14.
5. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Akao M, Ono K, Shioi T, Shizuta S, Sakata R, Okabayashi H, Nishiwaki N, Komiya T, Suwa S, Kimura T. Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization. Circ J. 2011;75(7):1616-25. Epub 2011 Apr 29.
6. Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, Hosogi S, Hirono A, Tanaka H, Tada T, Morimoto T, Shiomi H, Kozuma K, Inoue K, Suzuki N, Kimura T, Mitsudo K. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011 May 31;123(21):2382-91. Epub 2011 May 16.
7. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet. 2011 Aug 1;4(4):446-54. Epub 2011 Jun 2.
8. Funakoshi S, Furukawa Y, Ehara N, Morimoto T, Kaji S, Yamamuro A, Kinoshita M, Kitai T, Kim K, Tani T, Kobori A, Nasu M, Okada Y, Kita T, Kimura T; CREDO-Kyoto Investigators. Clinical characteristics and outcomes of Japanese women undergoing coronary revascularization therapy. Circ J. 2011;75(6):1358-67. Epub 2011 Apr 12.
9. Takeshi Kimura, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa and Kazushige Kadota, et al. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan Cardiovascular Intervention and Therapeutics, 2011, Volume 26, Number 3, Pages 234-245
10. Takeshi Kimura, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa and Kazushige Kadota, et al. Association of the use of proton pump inhibitors with adverse cardiovascular and bleeding outcomes after percutaneous coronary intervention in the Japanese real world clinical practice Cardiovascular Intervention and Therapeutics, 2011, Volume 26, Number 3, Pages 222-233
11. Imai S, Matsuda M, Hasegawa G, Fuui M, Obayashi H, Ozasa N, Kajiyama S: A simple meal plan of ‘eating vegetables before carbohydrate’ was more effective for achieving glycemic control than an exchange– based meal plan in Japanese patients with type 2 diabetes. Asia Pac J Clin Nutr 2011; 20 (2): 161-168
12. Ono K: MicroRNA links obesity and impaired glucose metabolism. Cell Res. 2011 in press.
13. Kaishi S, Takaya T, Morimoto T, Sunagawa Y, Kawamura T, Ono K, Shimatus A, Baba S. Heiki T, Nakahata T, Hasegawa K: Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes Am J Cell Physiol. 2011; 226:248-54.
14. Ono K, Kuwabara Y, Han J: MicroRNAs and Cardiovascular Diseases. FEBS J 2011 in press.
15. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa, S Elbahrawy A, Soeda T, Koizumi M, Masui T, Kawaguchi M, Takaori K, Doi R, Nishi E, Kakinoki R, Deng JM, Behringer RR, Nakamura T, and Uemoto S: Continuous cell supply from the Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet. 2011; 43: 34-41
16. Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, and Furuse M: Angulin/LSR defines cell corners for tricellular tight junction formation in epithelial cells. J. Cell. Sci. 2011; 15: 548-55.
17. Kanda K, Komekado H, Sawabu T, Ishizu S, Nakanishi Y, Nakatsuji M, Akitake-Kawano R, Ohno M, Hiraoka Y, Kawada M, Kawada K, Sakai Y, Matsumoto K, Kunichika M, Kimura T, Seno H*, Nishi E*, and ChibaT (*Co-corresponding author) Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signaling via enhanced ectodomain shedding of TNF-a EMBO Mol Med, 4:396-411, 2012.
18. Li J, Chu M, Wang S, Chan D, Qi S, Wu M, Zhou Z, Li Z, Nishi E, Qin J and Wong J Identification and Characterization of Nardilysin as a Novel Dimethyl H3K4 Binding Protein Involved in Transcriptional Regulation J Biol Chem, 287:10089-98, 2012.
19. Tian Y, Yuan Z, Liu Y, Liu W, Zhang W, Xue J, Shen Y, Liang X, Chen T, Kishimoto C: Pioglitazone modulates the balance of effector and regulatory T cells in apolipoprotein E deficient mice. Nutrition, Metabolism & Cardiovascular Disease 21, 25-32, 2011.
20. Shimada K, Murayama T, Yokode M, Kita T, Fujita M, Kishimoto C: Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production. Nutrition, Metabolism & Cardiovascular Disease 21, 672-678, 2011.
21. Shimada K, Mikami Y, Murayama T, Yokode M, Fujita M, Kita T, Kishimoto C: Atherosclerotic plaques induced by marble-buring befavior are stabilized by exercise training in experimental atherosclerosis. Int J Cardiol 151, 284-289, 2011.
22. Huachun W, Chunshen S, Hirokawa G, Xu J, Takahashi R, Shimada K, Kishimoto C, Iwai N: Plasma miR-124 as a biomarker for cerebral infarction. Biomedical Research 32, 135-141, 2011.
23. Shen Y, Yuan Z, Yin A, Liu Y, Xiao Y, Wu Y, Zhao Y, Yuling T, Wang L, Xiao L, Li W, Chen T, Kishimoto C: Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells. Atherosclerosis 218, 330-338, 2011.
24. Kishimoto C: Serial electrocardiographic changes in fluminant myocarditis. (Letter) Circ J 75, 2511, 2011.
25. Kishimoto C, Nimata M, Okabe T, Shioji K: Immunoglobulin treatment ameliorates myocardial injury in experimental autoimmune myocarditis associated with suppression of reactive oxygen species. Int J Cardiol (in press)
26. Shimada K, Hirano E, Kimura T, Fujita M, Kishimoto C: Carvedilol Reduces the Severity of Atherosclerosis in Apolipoprotein E-Deficient Mice via Reducing Superoxide Production. Exp Biol Med (in press)
27. Hirano E, Shimada K, Komiyama T, Fujita M, Kishimoto C: Erythromycin Treatment Suppresses Myocardial Injury in Autoimmune Myocarditis in Rats via Suppression of Superoxide Production. Int J Cardiol (in press)
28. Kishimoto C, Takamatsu N, Ochiai H, Kuribayashi K: Nucleotide differences of coxsackievirus B3 and chronic myocarditis. Exp Biol Medicine (in press)
29. Yuan Z, Wang X, Liu X, Kishimoto C: The role of FCγ receptors in atherosclerosis. Exp Biol Med 237, 609-616, 2012.
30. Ogura C, Ono K, Miyamoto S, Ikai A, Mitani S, Sugimoto N, Tanaka S, Fujita M. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension. Blood Press. 2012 in press.
31. Sowa N, Horie T, Kuwabara Y, Baba O, Watanabe S, Nishi H, Kinoshita M, Takanabe-Mori R, Wada H, Shimatsu A, Hasegawa K, Kimura T, and Ono K. MicroRNA 26b Encoded by the Intron of Small CTD Phosphatase (SCP) 1 Has an Antagonistic Effect on its Host Gene. Journal of Cellular Biochem. 2012 in press.
32. Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Intensity of Statin Therapy, Achieved LDL-C Levels and Cardiovascular Outcomes in Japanese Patients After Coronary Revascularization. Circ J. 2012; 76:1369-1379
33. Natsuaki M, Nakagawa Y, Morimoto T, Ono K, Shizuta S, Furukawa Y, Kadota K, Iwabuchi M, Kato Y, Suwa S, Inada T, Doi O, Takizawa A, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators. Impact of Statin Therapy on Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation (from the CREDO-Kyoto Registry Cohort-2). Am J Cardiol. 2012; 109:1387-96.
34. Wada H, Ura S, Satoh-Asahara N, Kitaoka S, Mashiba S, Akao M, Abe M, Ono K, Morimoto T, Fujita M, Shimatsu A, Takahashi Y, Hasegawa K. α1-Antitrypsin-low-density-lipoprotein Serves as a Marker of Smoking-specific Oxidative Stress. J Atheroscler Thromb 2012;19:47-58.
35. Wada H, Ura S, Kitaoka S, Satoh-Asahara N, Horie T, Ono K, Takaya T, Takanabe-Mori R, Akao M, Abe M, Morimoto T, Murayama T, Yokode M, Fujita M, Shimatsu A, Hasegawa K. Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjects. PLoS One. 2011;6:e29351.
36. Morita S, Matsumoto Y, Okuyama S, Ono K, Kitamura Y, Tomori A, Oyama T, Amano Y, Kinoshita Y, Chiba T, Marusawa H. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma. Carcinogenesis. 2011;32:1706-12.
37. Morigami Y, Ono K, Jinnai T, Tamura T, Watanabe S, Takai F, Osada H, Yamazaki K, Kita T, Sakata R, Kimura T. A case with giant right coronary artery aneurysm in a patient with Behcet’s disease. Journal of Cardiology Cases 2011;4:e76-e79.
38. Kanamori H, Takemura G, Goto K, Maruyama R, Ono K, Nagao K, Tsujimoto A, Ogino　A, Takeyama T, Kawaguchi T, Watanabe T, Kawasaki M, Fujiwara T, Fujiwara H,　Seishima M, Minatoguchi S. Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion. Am J Physiol Heart Circ Physiol. 2011;300:H2261-71.
39. Nishi H, Ono K, Horie T, Nagao K, Kinoshita M, Kuwabara Y, Watanabe S, Takaya T, Tamaki Y, Takanabe-Mori R, Wada H, Hasegawa K, Iwanaga Y, Kawamura T, Kita T, Kimura T. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta 1 in neonatal rat ventricular myocytes. Mol Cell Biol. 2011;31:744-55.
40. Niizuma S, Inuzuka Y, Okuda J, Kato T, Kawashima T, Tamaki Y, Iwanaga Y, Yoshida Y, Kosugi R, Watanabe-Maeda K, Machida Y, Tsuji S, Aburatani H, Izumi T, Kita T, Kimura T, Shioi T. Effect of persistent activation of phosphoinositide 3-kinase on heart. Life Sci. 90, 619-28, 2012
41. Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Kawamoto A, Tamaki Y, Iwanaga Y, Soga T, Kita T, Kimura T, Shioi T. Analysis of liver metabolism in a rat model of heart failure. Int J Cardiol. 161, 130-6, 2012
42. Kawashima T, Inuzuka Y, Okuda J, Kato T, Niizuma S, Tamaki Y, Iwanaga Y, Kawamoto A, Narazaki M, Matsuda T, Adachi S, Takemura G, Kita T, Kimura T, Shioi T. Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice. J Mol Cell Cardiol. 51, 1026-36, 2011

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.